tiprankstipranks
Oruka Therapeutics (ORKA)
NASDAQ:ORKA
US Market
ORKA
Oruka Therapeutics
RESEARCH TOOLSreports

Oruka Therapeutics (ORKA) Income Statement

762 Followers

Oruka Therapeutics Income Statement

Last quarter (Q4 2025), Oruka Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Oruka Therapeutics's net income was $-29.58M. See Oruka Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -83.00K$ -27.00K$ -114.00K$ -91.00K$ -93.00K
Operating Expenses
$ 121.97M$ 88.10M$ 9.73M$ 19.24M$ 9.67M
Depreciation and Amortization
$ 83.00K$ 27.00K$ 114.00K$ 91.00K$ 93.00K
EBITDA
$ -121.97M$ -82.23M$ -9.81M$ -19.23M$ -9.64M
Operating Income
$ -122.05M$ -88.12M$ -9.84M$ -19.34M$ -9.77M
Other Income/Expenses
$ 16.62M$ 4.40M$ -85.00K$ 13.00K$ 19.00K
Pretax Income
$ -105.43M$ -83.72M$ -9.93M$ -19.32M$ -9.75M
Net Income
$ -105.43M$ -83.72M$ -9.93M$ -19.32M$ -9.74M
Per Share Metrics
Basic EPS
$ -2.31$ -4.99$ -8.27$ -16.68$ -8.40
Diluted EPS
$ -2.31$ -4.99$ -8.27$ -16.68$ -8.40
Weighted Average Shares Outstanding
 45.61M 16.79M 14.41M 13.90M 4.71M
Weighted Average Shares Outstanding (Diluted)
 45.61M 16.79M 14.41M 13.90M 4.71M
Currency in USD

Oruka Therapeutics Earnings and Revenue History